Konstantinos Alataris's insider trading at Zosano Pharma
SEC Form 4 filings for Alataris Konstantinos, 34790 Ardentech Ct, Fremont, CA 94555, USA

Insider trading of Konstantinos Alataris, a President, CEO at ZSAN Zosano Pharma Corporation

Most recently Konstantinos Alataris exercised 127,389 shares worth $184,714.05 on 20 March 2017.

Date
#
Company
Insider Title
Trans.
Transaction
Shares Price per share Total price Shares after Source
2017-03-20 Konstantinos Alataris
President, CEO
President, CEO Option exercise 127,389 $1.45 $184,714
2017-03-20
254,778
2016-08-19 Konstantinos Alataris
President, CEO
President, CEO Buy 127,389 $1.32 $168,153
2016-08-19
127,389
Zosano Pharma Corporation logo

Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients. Its lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

  • Zosano Pharma Corporation, 34790 Ardentech Court, Fremont 94555, United States
  • zosanopharma.com
  • 510-745-1200
Messenger